Clinical trials recruiting for Obesity
1,512
Recruiting trials
49
US states with sites
78
Countries
37%
Accept healthy volunteers
Phase breakdown
Drugs and treatments being studied
| Intervention | Trials |
|---|---|
| Tirzepatide | 43 |
| Semaglutide | 28 |
| Metformin | 10 |
| NNC0487-0111 | 10 |
| Eloralintide | 9 |
| Maridebart cafraglutide | 8 |
| Cagrilintide | 6 |
| Orforglipron | 5 |
| UBT251 | 5 |
| IBI362 | 4 |
| Probiotic | 4 |
| Acetaminophen | 3 |
Where trials are recruiting (top US states)
| State | Recruiting trials |
|---|---|
| California | 121 |
| Texas | 109 |
| Florida | 92 |
| New York | 92 |
| North Carolina | 79 |
| Illinois | 71 |
| Maryland | 63 |
| Missouri | 63 |
| Pennsylvania | 62 |
| Massachusetts | 55 |
| Ohio | 55 |
| Arizona | 52 |
Top cities
Houston, Texas 56Chicago, Illinois 53San Antonio, Texas 49New York, New York 44Boston, Massachusetts 38Miami, Florida 35Dallas, Texas 33Los Angeles, California 30Aurora, Colorado 29Philadelphia, Pennsylvania 29
Self-screener
Recruiting trials
- "Improving Health and Reducing Chronic Disease Risk in Middle-Aged Adults Through Nutrition"
- "We Are an Active Family": Promoting Child Physical Activity Through Social Identity Formation in the Family System
- 'Ai Pono Cooking Demonstrations
- 2024 Tirzepatide-Bariatric Surgery
- 25(OH)-Vitamin D and Its Association With Structural and Functional Parameters in Hospitalized Patients With Neurological Diseases
- A Bilingual Virtually-based Intervention (PEDALL) for the Prevention of Weight Gain in Childhood ALL Patients Considering Key Genetic and Sociodemographic Risk Factors
- A Biological Atlas of Severe Obesity (Biological Tissue Collection)
- A Clincial Study Testing Tirzepatide on Reproductive Function and Metabolic Health in Women With PCOS Who Are Overweight or Obese
- A Clinical Study of Semaglutide Nasal Spray in Overweight or Obese Adults
- A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes
- A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes
- A Clinical Study to Evaluate the Efficacy and Safety of HRS9531 Tablets in Overweight or Obese Subjects
- A Clinical Trial Evaluating TQF3250 Capsules in Patients With Type 2 Diabetes Mellitus and Overweight/Obesity
- A Clinical Trial Using Tirzepatide to Help Adults With Type 1 Diabetes Automatically Control Their Blood Sugar
- A Combined Lifestyle Intervention Delivered by Physio/exercise Therapists for Patients with Persistent Low Back Pain and Overweight or Obesity
- A Culturally-relevant Micronutrient-dense Plant-rich (mNDPR) Dietary Intervention for Native Americans
- A Drug-Drug Interaction Study of HDM1002 and Metformin, Empagliflozin, Midazolam, Valsartan, and Warfarin
- A Feasibility Study of Optimal Non-Pharmacological Lifestyle Modifications in People With Type 2 Diabetes
- A First-In-Human Study of ARO-ALK7 in Adults With Obesity With and Without Type 2 Diabetes Mellitus
- A First-In-Human Study of ARO-INHBE in Adults With Obesity With and Without Type 2 Diabetes Mellitus
- A First-in-human Research Study on How NNC0721-8060 Works in People Living With Overweight or Obesity
- A Food-Effect Study of CX11 in Healthy Participants
- A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight
- A Master Protocol to Investigate Efficacy and Safety of Elecoglipron in Participants With Obesity or Overweight With or Without T2DM
- A Mobile Intervention to Reduce Pain and Improve Health-III
- A Multicenter Pharmacoepidemiological Cohort on Real Life Use of Semaglutide in Adolescents or Adults With Monogenic Obesity
- A Multicenter Retrospective Analysis of Postoperative Respiratory Complications in Children With Obstructive Sleepapnea
- A Multicenter Study for Evaluating a Digital Support System in Childhood Obesity Treatment
- A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Clinical Study to Evaluate the Efficacy and Safety of HRS9531 Injection in Subjects With Obstructive Sleep Apnea (OSA) and Obesity Who Are on Positive Airway Pressure Ventilation (PAP) Therapy
- A New Technological Intervention to Address Childhood Obesity:
- A Novel Digital Tool Physicians Can Use to Prescribe Exercise to Patients With Cardiovascular Disease Risk Factors
- A Novel Obesity Prevention Program for High-Risk Infants in Primary Care
- A Phase 1 Clinical Trial to Assess the Safety of DWRX5003 and Relative Bioavailability to DWC202502 and DWC202503 in Healthy Adult Volunteers
- A Phase 1, Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ISM8969
- A Phase 1/2a Study of WVE-007 in Adults Living With Overweight or Obesity
- A Phase 2 Study to Evaluate the Pharmacodynamics, Safety and Tolerability of BGE-102 in Participants With Obesity and Cardiovascular Risk Factors
- A Phase 2A Clinical Trial to Assess the Safety and Tolerability of ERX1000 in Men and Women for the Treatment of Obesity.
- A Phase I Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of HRS-5817 Injection
- A Phase I/IIa Clinical Study to Assess the Single and Multiple Ascending Doses of MDR-001 Tablets in Healthy Participants and Obese/ Overweight Participants
- A Phase III Study Evaluating the Efficacy and Safety of HRS9531 Injection in Subjects With Obstructive Sleep Apnea (OSA) and Obesity
- A Phase Ib/IIa Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Oral Ecnoglutide Tablets in Chinese Participants With Overweight or Obesity
- A Pilot Factorial Trial of an Integrated Lifestyle Intervention
- A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)
- A Proof-of-Concept Study to Evaluate Topical-Lingual Semaglutide in Adults With Obesity
- A Prospective Randomnised Controlled Trial Comparing Overall Patient Compliance in a Bariatric Surgical Pathway Using the Standard Versus a More Intensified and Interactive Version of the "Get Ready" Smartphone Application.
- A Randomized Controlled Study Evaluating Bariatric Surgery as a Treatment for Severe NASH With Advanced Liver Fibrosis in Non-severe Obese Patients
- A Research Study Comparing Different Ways of Increasing the Dose of NNC0662-0419 in Participants With Obesity
- A Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Living With Chronic Kidney Disease
- A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee Osteoarthritis Lose Weight and Reduce Pain
- A Research Study Investigating How a New Medicine NNC0113-5840 Works in People With Overweight or Obesity
- A Research Study Investigating the Effect of NNC0497-0040 in Healthy Participants, Participants With Overweight or Obesity, and Participants With Type 1 Diabetes With Overweight or Obesity
- A Research Study Looking Into How Cagrilintide Influences Food Intake and Appetite in People With Overweight or Obesity
- A Research Study Looking Into How NNC0662-0419 Works With Birth Control Pills and Emptying of the Stomach in Women Not Able to Become Pregnant With Excess Body Weight
- A Research Study Looking Into How UBT251 Works With Birth Control Tablets and Emptying of the Stomach in Women With Excess Body Weight Not Able to Become Pregnant
- A Research Study Looking at How NNC0487-0111 Affects Food Intake, Appetite and Metabolism After Meals in People With Obesity
- A Research Study on How UBT251 Affects Levels of Midazolam, Caffeine and Warfarin in the Blood of Participants With Excess Body Weight
- A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight
- A Research Study on How Well Different Doses of the Medicine UBT251 Help People Living With Overweight or Obesity
- A Research Study to Compare Blood Levels of Cagrilintide After Multiple Doses of Different Versions of Cagrilintide in Adults With Overweight or Obesity
- A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight
- A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
- A Research Study to See How NNC0487-0111 Affects the Body's Energy Use After a Weight Loss in Adults Living With Obesity, Compared to a Low-calorie Diet or Placebo
- A Self-Guided Mobile Intervention for Adults With Binge Eating and Obesity
- A Sensory Strategy to Cut Sugary Beverages in African/American and Latine Adolescents
- A Single and Multiple Ascending Dose Study of HM17321 in Healthy and Obese Participants
- A Single and Multiple Ascending Dose Trial Assessing Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ZP6590 in Participants With Normal Weight, Overweight and Obesity
- A Study Evaluating Mibavademab Treatment of Obesity Due to Leptin (LEP) Gene Mutations in Children, Adolescents and Adults
- A Study Investigating the Safety of RO7795081 and the Effect of RO7795081 on How the Body Processes Pitavastatin and Rosuvastatin in Otherwise Healthy Overweight or Obese Adult Participants
- A Study Investigating the Safety, Absorption, Elimination, and the Effect on the Immune System of ACI-19764 in Healthy Participants and in Participants With Cardiovascular Risk Factors
- A Study Looking at How Weekly Injections of Two Hormones - GIP and Amylin - Affect Stomach-related Side Effects in People Who Are Overweight or Obese
- A Study of ABBV-295 Subcutaneous Injections to Assess Adverse Events and Pharmacokinetics in Adult Participants With Obesity
- A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)
- A Study of BGM0504 Injection in Participants with Obesity or Overweight
- A Study of BGM0504 Tablets in Healthy and Non-diabetic Overweight or Obese Chinese Subjects
- A Study of BGM0504 in Early T2DM With Obesity
- A Study of BGM0504 in Participants With Obesity
- A Study of BGM1812 Injection in Healthy and Non-diabetic Overweight or Obese Chinese Participants
- A Study of CSTI-500 in Patients With Prader-Willi Syndrome
- A Study of DA-302168S in Participants With Overweight/Obesity
- A Study of Econoglutide Injection in Obese Participants With Knee Osteoarthritis (KOA)
- A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight
- A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
- A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes
- A Study of Eloralintide (LY3841136) in Participants With Obstructive Sleep Apnea and Obesity or Overweight
- A Study of Eloralintide (LY3841136) in Participants With Overweight or Obesity
- A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin
- A Study of HS-20094 in Overweight or Obese Participants
- A Study of IBI3032 in Chinese Healthy Participants and Participants With Overweight or Obesity
- A Study of IBI362 in Chinese Adolescents With Obesity or Overweight
- A Study of IBI362 in Chinese Subjects With Obstructive Sleep Apnea and BMI≥28 kg/m2
- A Study of IBI362 in Subjects With HFpEF or HFmrEF Combined With Obesity
- A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide
- A Study of LY4174794 in Participants With Obesity or Overweight Who Are Otherwise Healthy
- A Study of MET233 in Combination With MET097 in Individuals With Obesity or Overweight With or Without Diabetes
- A Study of Macupatide (LY3532226) and Eloralintide (LY3841136), Alone or in Combination, in Adults With Obesity or Overweight and With Type 2 Diabetes
- A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes
- A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities
- A Study of Orforglipron (LY3502970) in Adolescent Participants With Obesity, or Overweight With Related Comorbidities
- A Study of Orforglipron (LY3502970) in Participants With Obesity or Overweight and Osteoarthritis (OA) of the Knee
- A Study of Orforglipron in Female Participants With Stress Urinary Incontinence Who Have Obesity or Overweight
Related conditions
Trials recruiting for Obesity often also study these conditions. Each links to its own recruiting-trial list.
Type 2 diabetes 891Overweight 89Hypertension 1201Metabolic syndrome 64Insulin Resistance 61NASH 218Childhood Obesity 37Diabetes 99Cardiovascular Diseases 164Overweight or Obesity 33
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for Obesity trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.